NEU 0.79% $15.26 neuren pharmaceuticals limited

The Whens and Whys of Top Biotech M&A Deals, page-15

  1. 1,133 Posts.
    lightbulb Created with Sketch. 115
    And I think that’s the mail reason for the recent slide. It’s a different approach to what was expected, especially given the comments made by t20 holders who were predicting an early sale. I’ve held for a long time but I’m disappointed about a 4 year (+) further slog, and then in the absence of a TO, the prospect of going alone to market?
    But there’s still the same chance of an early TO offer. Here’s hoping.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.